Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
From Spravato (Esketamine) to COMP360 (Psilocybin): A New Chapter in ...
The Safety And Tolerability Of Comp360 (Psilocybin) In Participants ...
COMPASS Pathways completes COMP360 psilocybin therapy
COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 ...
Compass Psychological Support Model for COMP360 Psilocybin Treatment of ...
COMP360 Psilocybin Healthy Volunteers Study
The Breakthrough in Psilocybin Therapy: Why Compass Pathways' COMP360 ...
COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy ...
COMP360 psilocybin treatment in TRD with antidepressants | Compass Pathways
COMP360 Psilocybin Therapy Study Results by Compass Pathways
Magic mushroom drug COMP360 psilocybin used along with therapy can help ...
Compass Pathways gains after FDA clears IND for PTSD trial of COMP360
COMP360 psilocybin therapy shows potential in open-label study in type ...
COMP360 Psilocybin for Treatment-Resistant Depression Achieves Primary ...
COMP360 Psilocybin Therapy Shows Promise in Bipolar Disorder - Lucid News
Compass Pathways’ COMP360 Psilocybin Shows Benefit in Phase 3 TRD Trial ...
Unveiling COMP360 (Psilocybin): A New Hope for Treatment-Resistant ...
Compass Pathways Publishes Phase 2 Results of COMP360 Psilocybin in ...
Good Results for COMP360 Psilocybin in Bipolar Disorder Study | Microdose
COMP360 Psilocybin Shows 6-Month Depression Relief in Phase 2 Study ...
COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults ...
Phase 2 Study of COMP360 Psilocybin Finds Improved PTSD Symptoms ...
Compass Pathways Accelerates COMP360 Depression Therapy Launch by 9-12 ...
COMPASS Pathways Awarded Patent for Psilocybin Formulation COMP360 ...
COMP360 Algorithm Design - Coggle Diagram
FDA Accepts Investigational New Drug Application for COMP360 for PTSD ...
Compass Pathways Rises 10% After Positive Phase 3 Results for COMP360 ...
Compass' COMP360 Shows 82% PTSD Response Rate in Phase 2 Trial | CMPS ...
Compass Pathways to Report New Phase 3 Clinical Data for COMP360 in ...
COMP360 Timeline Accelerates: Compass Pathways Targets Early Depression ...
The Latest On Compass Pathways’ COMP360 Formulation - The Dales Report
COMP360 - Terapia com psilocibina mostra potencial no estudo open-label ...
Compass Pathways: Forging Independent Path With Competition Nearing ...
COMP 360 (psilocybin) for TRD, PTSD and Anorexia 14
Compass Pathways Successfully Achieves Primary Endpoint in Second Phase ...
About psilocybin therapy | Compass Pathways
Compass Pathways Successfully Achieves Primary Endpoint in First Phase ...
COMPASS Pathways announces positive outcome in exploratory study of ...
Compass Pathways Announces Dosing Complete for All Participants in Part ...
FDA accepts IND for synthetic psilocybin therapeutic to treat PTSD
Compass Pathways Announces Publication of Results from Phase 2 Study of ...
COMPASS Pathways | Mental Health Care Company
COMPASS Pathways announces positive topline results from groundbreaking ...
COMPASS leverages RealTime for Psilocybin Therapy Insights - Sermo
A Single Dose of Psilocybin for Treatment-Resistant Depression
Positive Data From COMPASS Pathways' Phase 2 Trial Combining Psilocybin ...
Compass Pathways' Psilocybin Therapy Achieves Key Phase 3 Milestone ...
Compass Pathways has just released topline results from the first-ever ...
Psychedelic Bulletin #120: Beckley Psytech Acquires Eleusis; A Look at ...
Psilocybin - Psychedelic Science Review
Compass Pathways Releases Promising New Data from Landmark Psilocybin ...
Compass Pathways, Hackensack Meridian Health collaborate on psilocybin ...
Comp360, LLC Online im App Store
COMPASS Pathways進一步推動COMP360於FDA的加速審核，並擴展PTSD計畫！-CMoney 研究員 | CMoney投資網誌
Compass Pathways gibt grünes Licht für Psilocybin-Studie zur Behandlung ...
Psychedelic therapy: Psilocybin shows promise as depression treatment ...
About psilocybin therapy | COMPASS Pathways
Our publications and results | Compass Pathways
…phase 3 [synthetic COMP360] psilocybin clinical trial is… to commence ...
Psi-Driven Progress: Compass Pathways’ Phase 3 Psilocybin Trial Nears ...
slide26
Journey Clinical and Compass Pathways Announce Research Collaboration ...
Psilocybin Breakthrough: Compass Pathways Completes Phase 3 Recruitment ...
Comp360, LLC Online - Apps on Google Play
The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off ...
PPT - COMP 360/560 Tutorial PowerPoint Presentation, free download - ID ...
Compass Pathways launches Phase 3 psilocybin trial in UK - NeoLumina
A milestone psilocybin therapy study from COMPASS Pathways has been ...
Compass Pathways: Promising Psychedelic Mental Health Therapies ...
Compass Pathways To Start Phase II Trial For Psilocybin PTSD Therapy ...
COMPASS Pathways presents largest ever study of psilocybin therapy, at ...
Is Psilocybin Really a Miracle Drug? Compass Pathways Releases Phase 2B ...
Single-dose psilocybin promising for resistant depression | MDedge
COMP401: Multi-centre clinical trial to investigate psilocybin therapy ...
This week, our Chief Medical Officer, Dr Guy Goodwin, presented new ...
Duke University launches centre for psychedelic science
Largest Psilocybin Therapy Trial Ever Conducted Shows Depressive ...
Compass Plots Path to FDA With ‘Meaningful’ Phase III Data for ...
Compass Pathways - Psilosybin (comp360) - Annet - TekInvestor - Norges ...
Psilocybin for Treatment-resistant Depression Study | McGovern Medical ...
slide12
COMPASS’ Published Results Take its Psilocybin into Final Phase of ...
The World’s Largest Psilocybin Therapy Trial Is Close to Completion ...
